Crossmark

Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study

Crossref DOI link: https://doi.org/10.1186/s12931-022-02190-8

Published Online: 2022-10-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bekbossynova, Makhabbat

Akhmaltdinova, Lyudmila

Dossybayeva, Kuanysh

Tauekelova, Ainur

Smagulova, Zauresh

Tsechoeva, Tatyana

Turebayeva, Gulsimzhan

Sailybayeva, Aliya

Kalila, Zhanar

Mirashirova, Tahmina

Muratov, Timur

Poddighe, Dimitri
Funding

Funding for this research was provided by:

Ministry of Education and Science of the Republic of Kazakhstan (10965164)
License Information

Text and Data Mining valid from 2022-10-10

Version of Record valid from 2022-10-10
More Information

Article History

Received: 29 July 2022

Accepted: 13 September 2022

First Online: 10 October 2022

Declarations

:

: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by local Ethics Committee of the NRCCS (Protocol no. 01-91/2021 dated on April 22nd, 2021) in agreement with the ethical principles of the State Standard for Good Clinical Practice, Rules for conducting biomedical research and requirements for research centers from December 21, 2020, № KR DSM-310/2020. Written and signed Informed consent to participate in this research was obtained of all patients involved in the study (or legally authorized guardian, if appropriate).

: Data are presented in aggregated forms and no patients’ individual data are included in the manuscript. Written and signed informed consent to participate in this research was obtained of all patients involved in the study (or legally authorized guardian, if appropriate).

: The authors have no competing interest to declare for this research.

Document is current

Any future updates will be listed below